Back to top
more

Lantheus (LNTH)

(Delayed Data from NSDQ)

$105.55 USD

105.55
1,119,849

+1.52 (1.46%)

Updated Sep 13, 2024 04:00 PM ET

After-Market: $105.57 +0.02 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 251)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Ethan Feller headshot

2 Top Ranked Stocks with Strong Momentum

by Ethan Feller

Using Zacks Premium Screens, I have identified three stocks with improving earnings expectations and strong momentum

Palo Alto Networks and RH have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Palo Alto Networks and RH are part of the Zacks Bull and Bear of the Day article.

Illumina (ILMN) Partners With Henry Ford Health for NGS Test

by Zacks Equity Research

Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease.

Lantheus Holdings (LNTH) Stock Moves 0.96%: What You Should Know

by Zacks Equity Research

Lantheus Holdings (LNTH) closed the most recent trading day at $86.35, moving +0.96% from the previous trading session.

Indrajit Bandyopadhyay headshot

3 Medical Product Stocks With Strong Potential to Gain in 2023

by Indrajit Bandyopadhyay

Here we discuss three medical instruments stocks, LNTH, RMTI and VMD, which are witnessing solid momentum in 2023. These stocks have the potential to continue their uptrend going forward.

Investors Heavily Search Lantheus Holdings, Inc. (LNTH): Here is What You Need to Know

by Zacks Equity Research

Lantheus Holdings (LNTH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Henry Schein (HSIC) Acquires Majority Stake in Biotech Dental

by Zacks Equity Research

Henry Schein (HSIC) announces that the completion of the Biotech Dental partnership brings forth the company's several important solutions to customers.

Quest Diagnostics (DGX) Advances Access to Transplant Services

by Zacks Equity Research

Quest Diagnostics' (DGX) upgrade to advanced diagnostics and support services is likely to feature personalized patient access to service centers and mobile phlebotomists.

Lantheus Holdings (LNTH) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Lantheus Holdings (LNTH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

by Zacks Equity Research

Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.

Zacks.com featured highlights Lantheus, Perion Network, Alliance Resource Partners and Sea

by Zacks Equity Research

Lantheus, Perion Network, Alliance Resource Partners and Sea have been highlighted in this Screen of The Week article.

Zacks.com featured highlights Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus

by Zacks Equity Research

Bellerophon Therapeutics, Crawford, Riley Exploration Permian, Harrow Health and Lantheus have been highlighted in this Screen of The Week article.

Here's What Makes UnitedHealth Group (UNH) a Lucrative Bet Now

by Zacks Equity Research

UnitedHealth Group (UNH) is well-poised for growth on the back of a growing customer base within its government businesses, efficient telehealth services and solid cash-generating abilities.

Is Lantheus (LNTH) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Lantheus Holdings (LNTH) and Novo Nordisk (NVO) have performed compared to their sector so far this year.

4 Top-Performing Liquid Stocks to Scoop for Strong Returns

by Zacks Equity Research

Here are four top-ranked liquid stocks, Lantheus Holdings (LNTH), Alliance Resource Partners (ARLP), Perion Network (PERI) and Sea Limited (SE), which investors can add to their portfolio for solid gains.

Nalak Das headshot

5 Stocks With Recent Price Strength Amid March Rally

by Nalak Das

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BLPH, CRD.B, REPX, HROW and LNTH.

Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Avis Budget Group and Vulcan Materials have been highlighted as Zacks Bull and Bear of the Day.

Indrajit Bandyopadhyay headshot

3 Medical Stocks Creating Wealth Despite Macro Challenges

by Indrajit Bandyopadhyay

Here we discuss three stocks - LNTH, OMER and HYPR - that have been creating wealth for their investors in 2023 even though several competitors faltered amid macro challenges. Will the trend continue?

Here's Why You Should Retain HCA Healthcare (HCA) Stock Now

by Zacks Equity Research

HCA Healthcare (HCA) remains well-poised for growth on the back of improved revenues, a well-diversified healthcare portfolio and sufficient cash-generating abilities.

Recent Price Trend in Lantheus Holdings (LNTH) is Your Friend, Here's Why

by Zacks Equity Research

Lantheus Holdings (LNTH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks.com featured highlights include Lantheus, Perion Network, Meta Platforms and Sea

by Zacks Equity Research

Lantheus, Perion Network, Meta Platforms and Sea are part of the Zacks Screen of the Week article.

Walgreens (WBA) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Walgreens' (WBA) strategic executions on the United States and the international front is likely to have contributed to the Q2 2023 top line.

Vaishali Doshi headshot

4 Top-Ranked Liquid Stocks for Strong Returns in 2023

by Vaishali Doshi

Here are four top-ranked liquid stocks, Lantheus Holdings (LNTH), Meta Platforms (META), Perion Network (PERI) and Sea Limited (SE), which investors can add to their portfolio for strong gains.

Does Lantheus Holdings (LNTH) Have the Potential to Rally 32.44% as Wall Street Analysts Expect?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 32.4% in Lantheus Holdings (LNTH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Has Cardiff Oncology (CRDF) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Cardiff Oncology (CRDF) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.